Patil, V., Joshi, A., Noronha, V., Agarwala, V., Chougule, A., Kanan, S., . . . Prabhash, K. (2019). Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer. Oncotarget.
Citación estilo ChicagoPatil, Vijay, et al. "Randomized Phase 3 Open Label Study of Quality of Life of Patients On Pemetrexed Versus Erlotinib As Maintenance Therapy for Advanced Non Squamous Non EGFR Mutated Non Small Cell Lung Cancer." Oncotarget 2019.
Cita MLAPatil, Vijay, et al. "Randomized Phase 3 Open Label Study of Quality of Life of Patients On Pemetrexed Versus Erlotinib As Maintenance Therapy for Advanced Non Squamous Non EGFR Mutated Non Small Cell Lung Cancer." Oncotarget 2019.